The Guzman y Gomez ASX IPO gained over 35% on its first trading day – but will the hot run last?
The Guzman y Gomez ASX IPO was a spectacular success. After months of rumours, and a few weeks marketing (and…
Read More
Share buybacks: Are they a good sign or a waste of money?
Share buybacks are a controversial topic amongst investors. Some say it is a waste of money, others will welcome it…
Read More
AFT Pharmaceuticals (ASX:AFP): A gem of a dual-listed healthcare company
AFT Pharmaceuticals (ASX:AFP) may not spring to mind as the best company to have come out of New Zealand. Many…
Read More